Search

everythinglearnresearchcommunity

for

Search:↓

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Trichoscopy effectively diagnoses allergic scalp contact dermatitis.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Inflammation damages sweat ducts, causing sweat gland injury.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

Daughters with affected mothers may develop frontal fibrosing alopecia early.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

The patient's hair loss is most likely due to diffuse alopecia areata.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Friedreich's ataxia causes thin, weak hair with surface damage and cavities.

Frontal fibrosing alopecia on limbs shows permanent inflammatory hair loss, not typical scarring.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

People with alopecia areata are more likely to get migraines, and vice versa.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Trichoscopy is a useful tool for diagnosing and assessing the severity of alopecia areata.

Hair shaft changes may be linked to CCCA, but their role is unclear.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.